| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/17/2011 | WO2011019681A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | WO2011019221A2 Agent for stimulating mobilization of endothelial progenitor cells |
| 02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
| 02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |
| 02/17/2011 | WO2011018763A1 Combination of proantocycidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis |
| 02/17/2011 | WO2011018700A1 Natural extract from whole banana fruit (musa spp.) |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018582A2 Floating microgranules |
| 02/17/2011 | WO2011017907A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | WO2011017810A1 Combination therapy to treat vascular disorders |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110040161 Device for generating a detectable signal based upon concentration of at least one substance |
| 02/17/2011 | US20110040144 Method and apparatus for weight control by olfactory nerve ablation |
| 02/17/2011 | US20110039935 Use of pharmacologically active chemical compounds |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039911 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039905 Benzimidazole derivatives as calcium channel blockers |
| 02/17/2011 | US20110039883 Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors |
| 02/17/2011 | US20110039878 Methods for reducing blood pressure |
| 02/17/2011 | US20110039876 Solution formulations of sirolimus and its analogs for cad treatment |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039871 Process for preparing bosentan |
| 02/17/2011 | US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii |
| 02/17/2011 | US20110039867 Pyrimidine derivatives which are antagonist of the vitronectin receptor |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039861 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039845 2-aminoquinazoline derivative |
| 02/17/2011 | US20110039841 Novel compounds, their preparation and use |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039799 A1 adenosine receptor agonist polymorphs |
| 02/17/2011 | US20110039795 2'-o,3'-n-bridged macrolides |
| 02/17/2011 | US20110039793 Application of ginsenoside Rb1 in preparing medicaments for treating dilated cardiomyopathy |
| 02/17/2011 | US20110039785 Polypeptide-nucleic acid conjugates and uses thereof |
| 02/17/2011 | US20110039783 Peptide having hypotensive activity |
| 02/17/2011 | US20110039778 Peptide Synthesis |
| 02/17/2011 | US20110039770 Inhibitors of protein kinase c isoforms and uses thereof |
| 02/17/2011 | US20110039768 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same, |
| 02/17/2011 | US20110039766 Methods for preventing or treating metabolic syndrome |
| 02/17/2011 | US20110038949 Homeopathic formulation |
| 02/17/2011 | US20110038931 Composite preparation |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038898 Dissolution properties of drug products containing olmesartan medoxomil |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038857 Novel aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 02/17/2011 | US20110038848 Dietary supplement compositions for cardiovascular health |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | CA2804755A1 Modified vasoactive intestinal peptides |
| 02/17/2011 | CA2771083A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771053A1 Floating microgranules |
| 02/17/2011 | CA2770793A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | CA2769764A1 Combination of proantocycidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis |
| 02/17/2011 | CA2769758A1 Natural extract from whole banana fruit (musa spp.) |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof |
| 02/16/2011 | EP2284158A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283838A2 Docosahexaenoic acid for treating subclinical inflammation |
| 02/16/2011 | EP2283837A2 Docosahexaenoic acid for treating subclinical inflammation |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283834A2 Therapeutic compositions comprising ketone bodies or their precursors |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283014A1 Polymorphs of hydrochloride salt o5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyridoý2,3-b¨indole-7-carboxamideand methods of use therefor |
| 02/16/2011 | EP2282757A1 Neutralization of gm-csf for the treatment of heart failure |
| 02/16/2011 | EP2282754A2 Method of treating peripheral arterial disease |
| 02/16/2011 | EP2282751A1 Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect |
| 02/16/2011 | EP2282748A2 Treatment of brain damage using umbilical cord blood cells |
| 02/16/2011 | EP2282733A2 Protection of normal cells |
| 02/16/2011 | EP1919469B1 Process for preparing an angiotensin ii receptor antagonist |
| 02/16/2011 | EP1827425B1 Use of ppar agonists for the treatment of congestive heart failure |
| 02/16/2011 | EP1773450B1 Therapeutically combinations |
| 02/16/2011 | EP1577388B1 Adiponectin promoter and use thereof |
| 02/16/2011 | EP1545609B1 Antibodies directed against oxidised apolipoprotein B |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1373207B1 Novel amlodipine camsylate and method for preparing thereof |
| 02/16/2011 | EP1222854B1 Prevention and treatment of diseases associated with blood coagulation |
| 02/16/2011 | CN1994385B Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 02/16/2011 | CN1919247B Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 02/16/2011 | CN1919240B Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 02/16/2011 | CN1872187B Application of medication composition of containing astragalus root in preparing medication for treating chronic insufficiency of supplying blood for brain |
| 02/16/2011 | CN1872077B Medicine for treating cardiac insufficiency |